Market Research Report
Anti-Parkinson's Drugs: Global Markets to 2022
|Published by||BCC Research||Product code||611045|
|Published||Content info||172 Pages
Delivery time: 1-2 business days
|Anti-Parkinson's Drugs: Global Markets to 2022|
|Published: March 7, 2018||Content info: 172 Pages||
The global anti-Parkinson's drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1% from 2017 to 2022.
This research report categorizes the anti-Parkinson's drugs market by type. Product types include low dopaminergic, dopamine agonists, enzyme inhibitors and other anti-Parkinson's medications.
Led by Research Head Karthik Arun, the BCC Research Staff is comprised of expert analysts skilled in conducting primary research, secondary research and data analysis and who have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in microbiology, electrical engineering, business administration and surgery, among others.